Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first261 to 280 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| GZMB granzyme B | 3002 HGNC:4709 | 1 | 94 | 0 | 0 | 10,374 | 24,508 |
| NF1 neurofibromin 1 | 4763 HGNC:7765 | 1 | 38 | 0 | 0 | 7,851 | 24,469 |
| TNFSF11 TNF superfamily member 11 | 8600 HGNC:11926 | 1 | 313 | 1 | 166 | 6,049 | 24,404 |
| NR3C1 nuclear receptor subfamily 3 group C member 1 | 2908 HGNC:7978 | 1 | 221 | 82 | 7,990 | 11,825 | 24,397 |
| PC pyruvate carboxylase | 5091 HGNC:8636 | 1 | 112 | 0 | 0 | 9,720 | 24,328 |
| AVP arginine vasopressin | 551 HGNC:894 | 1 | 81 | 0 | 0 | 6,406 | 24,273 |
| SLC2A1 solute carrier family 2 member 1 | 6513 HGNC:11005 | 1 | 83 | 0 | 0 | 9,116 | 23,998 |
| SERPINC1 serpin family C member 1 | 462 HGNC:775 | 1 | 192 | 15 | 360 | 3,744 | 23,976 |
| RNASE1 ribonuclease A family member 1, pancreatic | 6035 HGNC:10044 | 1 | 138 | 0 | 0 | 11,173 | 23,900 |
| TOP2A DNA topoisomerase II alpha | 7153 HGNC:11989 | 1 | 90 | 26 | 4,309 | 7,493 | 23,720 |
| PROM1 prominin 1 | 8842 HGNC:9454 | 1 | 189 | 0 | 0 | 7,395 | 23,581 |
| LPL lipoprotein lipase | 4023 HGNC:6677 | 1 | 111 | 0 | 0 | 7,630 | 23,575 |
| DPP4 dipeptidyl peptidase 4 | 1803 HGNC:3009 | 1 | 255 | 23 | 745 | 6,254 | 23,557 |
| PPARGC1A PPARG coactivator 1 alpha | 10891 HGNC:9237 | 1 | 76 | 0 | 0 | 9,034 | 23,520 |
| B2M beta-2-microglobulin | 567 HGNC:914 | 1 | 755 | 0 | 0 | 9,221 | 23,517 |
| SERPINA1 serpin family A member 1 | 5265 HGNC:8941 | 1 | 596 | 0 | 0 | 8,180 | 23,491 |
| IL7 interleukin 7 | 3574 HGNC:6023 | 1 | 465 | 0 | 0 | 11,073 | 23,434 |
| CSF1 colony stimulating factor 1 | 1435 HGNC:2432 | 1 | 169 | 2 | 11 | 11,152 | 23,393 |
| CYP19A1 cytochrome P450 family 19 subfamily A member 1 | 1588 HGNC:2594 | 1 | 46 | 7 | 1,056 | 7,274 | 23,313 |
| NANOG Nanog homeobox | 79923 HGNC:20857 | 1 | 121 | 0 | 0 | 8,673 | 23,139 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=14
{
"data": {
"total": 193990,
"results": [
{
"id": "3002",
"title": "GZMB: granzyme B",
"summary": "NCBI Gene 3002. 1 protein, 94 patents, 0 drugs, 0 trials, 10,374 NIH grants and 24,508 papers.",
"record": "/library/genes/3002",
"gene_id": 3002,
"symbol": "GZMB",
"name": "granzyme B",
"hgnc_id": "HGNC:4709",
"counts": {
"proteins": 1,
"patents": 94,
"drugs": 0,
"trials": 0,
"grants": 10374,
"papers": 24508
}
},
{
"id": "4763",
"title": "NF1: neurofibromin 1",
"summary": "NCBI Gene 4763. 1 protein, 38 patents, 0 drugs, 0 trials, 7,851 NIH grants and 24,469 papers.",
"record": "/library/genes/4763",
"gene_id": 4763,
"symbol": "NF1",
"name": "neurofibromin 1",
"hgnc_id": "HGNC:7765",
"counts": {
"proteins": 1,
"patents": 38,
"drugs": 0,
"trials": 0,
"grants": 7851,
"papers": 24469
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=15",
"request_id": "cOa9-Zk_uWHUU_aN"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant